Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Vapreotide acetate | 849479-74-9 | 98.2% | 1191.42 | 10 MG
SDP

Catalog No. 5000426312
Encompass_Preferred

Vapreotide acetate is a neurokinin-1 (NK1) receptor antagonist with an IC50 of 330 nM. It is intended for research use only.

  • Attenuates Substance P (SP)-triggered intracellular calcium increases and NF-κB activation.
  • Inhibits SP-induced IL-8 and MCP-1 production.
  • Inhibits HIV-1 infection of human MDM in vitro.
  • Inhibits GH-, PRL, and/or alpha-subunit release by human GH-secreting pituitary adenoma cells.
  • Exhibits affinities for SSTR2, -3, and -5.
  • Reduces tumor volumes and weights in androgen-independent prostate cancer xenografts.
  • Decreases collateral circulation blood flow in cirrhosis and attenuates its development.

Catalog No. 50-004-26312 Supplier Medchemexpress LLC Supplier No. HYP0061A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Vapreotide acetate is a neurokinin-1 (NK1) receptor antagonist with an IC50 of 330 nM. It is intended for research use only.

  • Attenuates Substance P (SP)-triggered intracellular calcium increases and NF-κB activation.
  • Inhibits SP-induced IL-8 and MCP-1 production.
  • Inhibits HIV-1 infection of human MDM in vitro.
  • Inhibits GH-, PRL, and/or alpha-subunit release by human GH-secreting pituitary adenoma cells.
  • Exhibits affinities for SSTR2, -3, and -5.
  • Reduces tumor volumes and weights in androgen-independent prostate cancer xenografts.
  • Decreases collateral circulation blood flow in cirrhosis and attenuates its development.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.